Company Profile

Aerami Therapeutics is developing differentiated inhaled therapies for the treatment of severe respiratory and other chronic diseases. Our platform is designed to overcome the limitations of injectable, oral, and other inhaled formulation technologies for managing severe respiratory and other chronic diseases. Ultimately, our aim is to improve treatment efficacy and improve patient lives.

Industry Classifications

Sector:
Sector

Industry:
Industry

NAICS:
NAICS

SIC:
SIC

Contact Information

Investor Relations
Steve Thornton
T: 919-589-8862
sthornton@aerami.com

Company Contact
Aerami Therapeutics Holdings, Inc.
600 Park Offices Drive
300
Durham, NC 27709
info@aerami.com